News - 07 May `26Vitiligo Coverage: The Battle for H.1115 Isn't Over Yet

New

Vitiligo Coverage: The Battle for H.1115 Isn't Over Yet

A brief policy update from the long road toward fair insurance coverage for vitiligo.

Massachusetts Keeps Vitiligo Insurance Coverage on the Table

Sometimes advocacy doesn’t arrive with fireworks and a brass band. Sometimes it shows up in a quiet committee room, wearing a suit and carrying a bill number.

It might not look like a space battle, but for people living with vitiligo, this is exactly where the front line is drawn.

During the recent Massachusetts Dermatology Advocacy Day, State Representative Rob Consalvo reportedly spoke out once again for H.1115, “An Act requiring full health insurance coverage for individuals with vitiligo.”

The bill was filed by Representatives Rob Consalvo and John J. Lawn, Jr., with Representative Lindsay N. Sabadosa also listed in the petition, and referred to the Joint Committee on Financial Services in February 2025. A public hearing was held on October 8, 2025. In March 2026, the bill was accompanied by study order H.5225.

In plain English? It is not law yet. It is effectively parked for now. But in policy work, being parked does not mean being forgotten. The issue remains formally alive in the Massachusetts legislative record.

And that matters.

More Than Just Paperwork

H.1115 is a direct challenge to one of the oldest assumptions about vitiligo: that it is “merely cosmetic.”

The bill seeks coverage for vitiligo treatment across state employee plans, Medicaid, private insurance, hospital service plans, medical service corporations, and HMOs. It also includes mental health treatment connected to vitiligo — a small phrase with a massive moral spine.

For decades, patients have heard some version of this: “We see the condition, but we don’t think treating it is medically necessary.”

That logic is getting harder to defend.

Vitiligo is a chronic autoimmune disease. It can affect identity, childhood development, work, relationships, and mental health. Treating it as “decorative medicine” is not science. It is bureaucracy with a clipboard and a bad attitude.

The Long Game

Rep. Consalvo is not new to this fight. In 2023, he hosted a legislative briefing for the earlier version of the bill, H.976, standing with patient advocates like Valarie Molyneaux and Vicki Tiarht from VITFriends. His continued support helps keep this issue visible where it belongs: inside the rooms where access to care is decided.

This is not a victory lap. The bill has not passed, so keep the champagne in the cooler. But it is still news.

Real change rarely happens in one cinematic moment. It happens when patients, doctors, legislators, and advocates keep bringing the same uncomfortable truth back into the room:

  • Vitiligo is not vanity.
  • Access to treatment should not depend on whether an insurance adjuster “gets” the disease.
  • People living with vitiligo deserve care that reflects modern medicine, not outdated prejudice.

Massachusetts has not crossed the finish line yet. But the door is still open.

And in advocacy, an open door is where the real work begins.

Yan Valle

Prof. h.c., CEO VRF

Keep reading

Listen to Deep Dive in Vitiligo podacst



      FAQOther Questions

      • What tests for vitiligo should be done?

        Before starting vitiligo therapy, several tests may be recommended to ensure an accurate diagnosis and appropriate treatment plan: Physical Examination A thorough physical exa...

      • Vitiligo and hearing loss: any connection?

        Vitiligo is primarily recognized for causing skin discoloration, but it can also impact melanocytes in unexpected areas, such as the inner ear. This raises questions about wheth...

      • What causes vitiligo?

        The exact cause is a complex puzzle, but we know the foundation: It is pre-wired in your genes. Think of your genetics as a loaded spring, just waiting for a specific "trigger" ...